Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.72)
# 716
Out of 4,868 analysts
40
Total ratings
52.5%
Success rate
8.33%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXS NeurAxis | Initiates: Buy | $7 | $2.54 | +175.59% | 1 | Jun 16, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $12 → $17 | $10.90 | +55.96% | 2 | Jun 9, 2025 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $12 → $13 | $7.84 | +65.82% | 5 | May 14, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $28 | $13.67 | +104.83% | 6 | May 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $4.58 | +41.92% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $19.43 | +100.72% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.70 | +1,044.82% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $14.16 | +48.31% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $3.25 | +84.62% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.92 | +206.12% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.31 | +202.11% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $13.90 | +15.11% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $65 | $31.52 | +106.22% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $5.90 | +103.39% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.79 | +28.37% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $9.32 | +146.78% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.59 | +103.80% | 2 | Jul 11, 2023 |
NeurAxis
Jun 16, 2025
Initiates: Buy
Price Target: $7
Current: $2.54
Upside: +175.59%
Phathom Pharmaceuticals
Jun 9, 2025
Maintains: Buy
Price Target: $12 → $17
Current: $10.90
Upside: +55.96%
Fennec Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $12 → $13
Current: $7.84
Upside: +65.82%
Eton Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $26 → $28
Current: $13.67
Upside: +104.83%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $4.58
Upside: +41.92%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $19.43
Upside: +100.72%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.70
Upside: +1,044.82%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.16
Upside: +48.31%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.25
Upside: +84.62%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.92
Upside: +206.12%
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $3.31
Upside: +202.11%
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $13.90
Upside: +15.11%
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $31.52
Upside: +106.22%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $5.90
Upside: +103.39%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.79
Upside: +28.37%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $9.32
Upside: +146.78%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.59
Upside: +103.80%